| 2025 | | Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer
Cancer research communications, 5(12). : 2127-2141, 2025 | 김석휘 |
| 2025 | | Dysregulation of FGFR1 signaling in the hippocampus facilitates depressive disorder
Experimental & molecular medicine, 57(8). : 1818-1836, 2025 | 김석휘 |
| 2025 | | High Neutrophil-to-Lymphocyte Ratio Predicts a Suppressive Immune Microenvironment and Basal-Like Subtype in Pancreatic Cancer
Journal of gastroenterology and hepatology, 40(10). : 2623-2631, 2025 | 김석휘, 김유선, 양민재, 유병무, 이다근, 정우현, 최재일, 황재철 |
| 2025 | | Comparison of treatment strategies for submucosal tumors originating from the muscularis propria at esophagogastric junction or cardia
World journal of gastroenterology, 31(23). : 106261-106261, 2025 | 김석휘, 손상용, 송정호, 신성재, 이길호, 임선교, 한상욱, 허훈 |
| 2025 | | Optogenetically Activatable MLKL as a Standalone Functional Module for Necroptosis and Therapeutic Applications in Antitumoral Immunity
Advanced science (Weinheim, Baden-Württemberg, Germany), 12(13). : e2412393-e2412393, 2025 | 김석휘, 김유선, 이다근, 최재일 |
| 2025 | | Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel
Cancer research and treatment, 57(2). : 350-361, 2025 | 권민석, 김석휘, 김장희, 김태환, 노진, 박준성, 안미선, 이현우, 최용원 |
| 2025 | | A Multicenter Study on Hepatocellular Adenomas in Korea: Clinicopathological and Imaging Features With an Emphasis on β-Catenin Mutated Subtype
Liver international, 45(4). : e16155-e16155, 2025 | 김석휘, 허지미 |
| 2024 | | A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types
NPJ precision oncology, 8(1). : 277-277, 2024 | 김석휘 |
| 2024 | | Clinical application of whole-genome sequencing of solid tumors for precision oncology
Experimental & molecular medicine, 56(8). : 1856-1868, 2024 | 강석윤, 고영화, 곽규성, 권민석, 김석휘, 김선일, 김세혁, 김장희, 김재근, 김창우, 김철호, 김태환, 노성현, 노진, 노충균, 박지원, 박지은, 백수연, 손상용, 신승수, 안미선, 양민재, 유우식, 윤재성, 이기명, 이길호, 이다근, 이현우, 임선교, 장전엽, 정윤정, 조대성, 최용원, 최진혁, 하태양, 한상욱, 허지미, 허훈 |
| 2024 | | Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer
JCO precision oncology, 8. : e2300556-e2300556, 2024 | 김석휘 |
| 2024 | | Artificial intelligence-based real-time histopathology of gastric cancer using confocal laser endomicroscopy
NPJ precision oncology, 8(1). : 131-131, 2024 | 김석휘, 이다근 |
| 2024 | | Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression
The Journal of dermatology, 51(5). : 722-726, 2024 | 강희영, 김석휘, 김진철, 박영준 |
| 2024 | | Real-time Histological Evaluation of Gastric Cancer Tissue by Using a Confocal Laser Endomicroscopic System
In vivo (Athens, Greece), 38(2). : 855-863, 2024 | 김석휘 |
| 2024 | | Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Journal for immunotherapy of cancer, 12(2). : e008339-e008339, 2024 | 김석휘 |
| 2023 | | Simultaneous establishment of pancreatic cancer organoid and cancer-associated fibroblast using a single-pass endoscopic ultrasound-guided fine-needle biopsy specimen
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 35(7). : 918-926, 2023 | 김석휘, 양민재, 유병무, 이다근, 황재철 |
| 2023 | | Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer
NPJ breast cancer, 9(1). : 71-71, 2023 | 김석휘 |
| 2023 | | Artificial Intelligence in the Pathology of Gastric Cancer
Journal of gastric cancer, 23(3). : 410-427, 2023 | 김석휘 |
| 2023 | | EUS-guided tissue acquisition using a novel torque technique is comparable with that of the fanning technique for solid pancreatic lesions: A multicenter randomized trial
Journal of hepato-biliary-pancreatic sciences, 30(5). : 693-703, 2023 | 김석휘, 양민재 |
| 2023 | | Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
Cancer communications (London, England), 43(4). : 455-479, 2023 | 김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정 |
| 2022 | | Lymphatic-Venous Malformation Presenting as a Mediastinal Mass in a 6-Year-Old Boy
The Journal of emergency medicine, 63(1). : e42-e44, 2022 | 김석휘, 김중헌, 박지은, 장전엽 |
| 2022 | | Estrogen-responsive cancer-associated fibroblasts promote invasive property of gastric cancer in a paracrine manner via CD147 production
FASEB journal, 36(11). : e22597-e22597, 2022 | 김석휘, 이다근, 한재호 |
| 2022 | | Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response
European journal of cancer (Oxford, England : 1990), 170. : 17-26, 2022 | 김석휘 |
| 2022 | | miR-4742–5p promotes invasiveness of gastric cancer via targeting Rab43: An in vitro study
Biochemical and biophysical research communications, 613. : 180-186, 2022 | 김석휘, 김유선, 이다근 |
| 2022 | | Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms
Diagnostics (Basel, Switzerland), 12(10). : 2340-2340, 2022 | 김석휘 |
| 2022 | | Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer
Journal of clinical oncology, 40(17). : 1916-1928, 2022 | 김석휘 |
| 2021 | | MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer
Modern pathology, 34(3). : 672-683, 2021 | 김석휘, 배원정, 이다근 |
| 2021 | | Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer
Gastric cancer, 24(3). : 577-588, 2021 | 김석휘, 이다근, 한재호 |
